KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Astrana Health (ASTH) over the last 14 years, with Q3 2025 value amounting to $96000.0.

  • Astrana Health's Dividends Paid - Common fell 5596.33% to $96000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 8667.52%. This contributed to the annual value of $4.0 million for FY2024, which is 9349.81% down from last year.
  • Latest data reveals that Astrana Health reported Dividends Paid - Common of $96000.0 as of Q3 2025, which was down 5596.33% from $778000.0 recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Dividends Paid - Common registered a high of $59.8 million during Q4 2023, and its lowest value of $95000.0 during Q1 2024.
  • Over the past 5 years, Astrana Health's median Dividends Paid - Common value was $1.3 million (recorded in 2022), while the average stood at $6.5 million.
  • In the last 5 years, Astrana Health's Dividends Paid - Common tumbled by 9879.75% in 2022 and then surged by 564210.53% in 2025.
  • Over the past 5 years, Astrana Health's Dividends Paid - Common (Quarter) stood at $10.0 million in 2021, then crashed by 86.43% to $1.4 million in 2022, then skyrocketed by 4317.13% to $59.8 million in 2023, then tumbled by 96.79% to $1.9 million in 2024, then tumbled by 95.01% to $96000.0 in 2025.
  • Its Dividends Paid - Common stands at $96000.0 for Q3 2025, versus $778000.0 for Q2 2025 and $5.5 million for Q1 2025.